Rigel S.p.A. and FAI Instruments S.r.l.: A New Era of Innovation and Growth

📢 We are thrilled to announce that FAI Instruments S.r.l. has officially merged into Rigel S.p.A.!

This strategic decision strengthens our market presence and allows us to deliver even more advanced solutions to meet the needs of our clients. Together, we bring expertise, innovation, and a shared vision for the future.

What Does This Mean for You?

✔️ A Unified Team: an integrated structure to provide swift and effective responses.
✔️ Enhanced Expertise: a unique combination of know-how to develop tailored solutions.
✔️ Expanded Offering: new products and services while maintaining the quality and reliability you trust.

Looking Ahead

This merger represents an opportunity to tackle the challenges of an evolving market with greater strength and strategic vision. Together, we are ready to shape a future filled with innovation and opportunities, leveraging the synergies this integration offers.

💡 Thank you for your trust. We are excited to continue this journey together.

For more information, feel free to contact us or read our dedicated article: –> Merger Press Release

New plans for the Rigel S.p.A. Group

Rome, October 30th 2024 – Rigel S.p.A,

European leader in contamination control, has presented at the Annual Strategic Meeting the strategies which will guide its global expansion in the next five years.

The plan provides for a targeted strengthening of current assets, with clear objectives of optimizing the products portfolio, enhancing internal skills, strengthening of the brand and continuous innovation.

The ambitious initiative, illustrated by the Chief executive Officer Antonio Rachini, has instilled great interest among field experts Giovanni Scialò and Claudio Cafasso, who were present at the event and intend to invest in Rigel.

Also supporting this strategy Daniele Pandolfi will be part of the team, recognized expert in contamination’s monitoring in aseptic environments, who will be the Global Development & Strategic Director starting November 4th. Pandolfi’s extensive experience and his strategic vision for emerging markets is going to contribute in a significative way to Rigel’s International Growth.

Founded in 2008, Rigel is a European group specialized in advanced solutions for contamination’s control in aseptic environments, with applications in areas of high qualification like pharmaceutical production, healthcare sector and Aerospace. Amidst its advanced solutions, Rigel encloses systems for management, monitoring and validation of microbiologic and particles contamination levels in areas of controlled contamination, besides a complete range of portable instruments for HEPA filters’ leak-test.
Moreover, Rigel is distributor for the national market of QC’s consumables and production and it also has a ISO 17025 Calibration Accredited center.

With main locations in Rome and Milan, Rigel works through subsidiaries in France, Hungary, Turkey and United Arab Emirates, reinforcing its global presence and answering all the needs of a market in continuous evolution.

For further informations, please write to Katia Chiari at the following address katia.chiari@rigel-ls.com .

Rigel S.p.A gets ‘badge’ from EcoVadis

Rigel S.p.A is proud to have reached this highly coveted achievement. It’s absolutely not a finishing point, but only the beginning of a process in which the entire Rigel S.p.A. group believes with conviction. Environment, Employment and Human Rights, Ethics and Sustainable Purchasing are topics to be associated with the social and technical philosophy of our group.

Continue reading

Participation at CLEAN TECH 2022

We are delighted to announce our participation at Cleantech 2022 – the faculty of the future, sponsored by ASCCA, focused on innovative approaches in the design, realization and environmental monitoring of a cleanroom.

Continue reading

Mintaka Life Sciences joins Rigel Leading Solutions

“With this accomplishment, Rigel Leading Solutions is enriched with an active presence in the United Arab Emirates, an area in which Rigel over the years has developed a very important customer base, made up of leading pharmaceutical companies and prestigious hospitals. In this way we are going to establish a stable base to provide specialized technical assistance services for Climet particle counters and Rigel Life Sciences monitoring systems. ” Antonio Rachini, VP and Founder.

As a company, we look forward to serving more clients by providing customized solutions for clean environments.

Rigel Announces Completion of Fai Instruments and Inoki Acquisition

Rigel S.p.a. is proud to announce that the purchase of the companies Fai Instruments S.r.l. and Inoki S.r.l. has been finalized today.

The notarial deed was signed over Notary Borea’s office in Pistoia by Mr. Antonio Rachini, acting as Rigel’s managing director, by Mr. Antonio Imperatore, acting as Fai Instruments’ and Inoki’s founder, and Mr. Fabrizio Felippone acting as Ceo of Project Automation the minority share-holder in Fai Instruments.

Rigel, since it started in 2008, is a contamination control specialist in controlled environments successfully operating its brands Rigel Life Sciences and Rigel Process & Lab in many fields, especially within the pharmaceutical industry, healthcare and space agencies.

Rigel, in order to expand and consolidate its business, since 2018, controls Jointech S.r.l., an engineering company producing supervision and automation industrial systems. Furthermore, since 2019, controls Orion S.A.s, a subsidiary company operating in the francophone market.

Fai Instruments and Inoki acquisition is therefore part of a wide business strategy with the aim to strengthen Rigel’s leading position in the market.

In fact by purchasing Fai Instruments Rigel will be able to expand its business in the air pollution control industry, whilst by acquiring Inoki – a commercial brokerage company – Rigel will be able to forge a direct partnership with some of the most important production equipment manufacturers.

The strong synergies among the parts both in skills and in products offer are the most evident value this business transaction will allow, beyond any commercial advantage.